JPWO2023199893A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023199893A5
JPWO2023199893A5 JP2024514957A JP2024514957A JPWO2023199893A5 JP WO2023199893 A5 JPWO2023199893 A5 JP WO2023199893A5 JP 2024514957 A JP2024514957 A JP 2024514957A JP 2024514957 A JP2024514957 A JP 2024514957A JP WO2023199893 A5 JPWO2023199893 A5 JP WO2023199893A5
Authority
JP
Japan
Prior art keywords
orexin
neurodegenerative disease
sample
species
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024514957A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023199893A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/014583 external-priority patent/WO2023199893A1/ja
Publication of JPWO2023199893A1 publication Critical patent/JPWO2023199893A1/ja
Publication of JPWO2023199893A5 publication Critical patent/JPWO2023199893A5/ja
Pending legal-status Critical Current

Links

JP2024514957A 2022-04-11 2023-04-10 Pending JPWO2023199893A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022065117 2022-04-11
PCT/JP2023/014583 WO2023199893A1 (ja) 2022-04-11 2023-04-10 活性型オレキシンａを定量する方法

Publications (2)

Publication Number Publication Date
JPWO2023199893A1 JPWO2023199893A1 (https=) 2023-10-19
JPWO2023199893A5 true JPWO2023199893A5 (https=) 2024-12-24

Family

ID=88329773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024514957A Pending JPWO2023199893A1 (https=) 2022-04-11 2023-04-10

Country Status (5)

Country Link
US (1) US20250189543A1 (https=)
EP (1) EP4478051A4 (https=)
JP (1) JPWO2023199893A1 (https=)
CN (1) CN118984938A (https=)
WO (1) WO2023199893A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025137359A1 (en) * 2023-12-20 2025-06-26 Eisai R&D Management Co., Ltd. Assay methods to identify a disease
WO2025183053A1 (ja) * 2024-02-29 2025-09-04 株式会社島津製作所 生体液中のタウタンパク質の翻訳後修飾および／または断片化の質量分析法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000516456A (ja) * 1996-08-02 2000-12-12 ザ・スクリプス・リサーチ・インステイチユート 視床下部特異的ポリペプチド
EP1190089A4 (en) * 1999-06-25 2002-10-16 Smithkline Beecham Corp LIG 72A TREATMENT PROCESS AND VARIANTS THEREOF
WO2003092581A2 (en) * 2001-07-16 2003-11-13 Hk Pharmaceuticals, Inc. Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
WO2018078018A2 (en) * 2016-10-27 2018-05-03 Glostrup Hospital Detection of hypocretin-1 and -2

Similar Documents

Publication Publication Date Title
JPWO2023199893A5 (https=)
US12105101B2 (en) Assay for the detection of alpha-synuclein seeding activity associated with synucleinopathies
Michel et al. Proteome analysis of human plasma and amniotic fluid by Off‐Gel™ isoelectric focusing followed by nano‐LC‐MS/MS
US12085565B2 (en) SNTF is a blood biomarker for the diagnosis and prognosis of sports-related concussion
JP4659025B2 (ja) 神経系傷害および他の神経障害についての生物マーカーとしての神経タンパク質
US12000844B2 (en) Diagnostic drug and diagnostic method for Alzheimer's disease
JP2013092538A (ja) 脳損傷関連障害の診断法
DK2444814T5 (en) Biomarker for mental disorders, including cognitive disorders, and method of using the biomarker for detecting mental disorders, including cognitive disorders
CA2689024A1 (en) High sensitivity immunoassays and kits for the determination of peptidesand proteins of biological interest
WO2010052939A1 (ja) アレルゲンのエピトープ又はその候補の検出方法及びその利用
Haußmann et al. Analysis of amino-terminal variants of amyloid-β peptides by capillary isoelectric focusing immunoassay
RU2003105882A (ru) Упорядоченный железосодержащий белок-2 в качестве диагностического средства при нейродегенеративных заболеваниях
EP4101465A1 (en) Determination agent and determination method for tauopathy and dementia-related diseases
EP3287789B1 (en) Composition and kit for diagnosing behavioral addiction, and method of detecting neuropilin-2 for diagnosis of behavioral addiction
JP6870468B2 (ja) ペプチドの分析方法
JP2025060925A5 (https=)
EP3435085A1 (en) Composition and kit for diagnosing behavioral addiction, and method of detecting presenilin-1 for diagnosis of behavioral addiction using the same
EP2344881A1 (en) Alzheimer's disease biomarkers
JP2009092550A (ja) うつ病またはうつ状態の同定方法
JP6967206B2 (ja) 認知機能障害疾患のバイオマーカー及び該バイオマーカーを用いる認知機能障害疾患の検出方法
CN105254757A (zh) 羊抗兔β防御素124多克隆抗体及其制备方法和应用
US12269871B2 (en) Generation of a new site-specific monoclonal antibody for tau protein and its use as a tool in specific biomarkers for early detection of neurodegenerative diseases and pathologies
US20210156871A1 (en) Peptide analyzing method
CN112924684B (zh) 用于区分抑郁症和非抑郁症的生物标志物和包括其的诊断试剂盒
HK40048565A (en) Diagnostic drug and diagnostic method for alzheimer's disease